WDR35-DT: A Potential Drug Target and Biomarker (G101928222)
WDR35-DT: A Potential Drug Target and Biomarker
WDR35, a gene located on chromosome 6q21, has been identified as a potential drug target and biomarker for various diseases, including cancer. The WDR35 gene is associated with the development and progression of various diseases, including neurodegenerative disorders, cardiovascular diseases, and autoimmune diseases.
WDR35 is a non-coding RNA gene that encodes a protein known as WDR35-DT. WDR35-DT is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, and peripheral tissues. It is involved in various cellular processes, including cell adhesion, migration, and survival.
Studies have shown that WDR35-DT is involved in the development and progression of various diseases, including cancer. For example, WDR35-DT has been shown to be overexpressed in various cancer types, including breast, ovarian, and colorectal cancers. Additionally, it has been shown to be involved in the regulation of cell proliferation and apoptosis, which are important processes that are altered in cancer.
As a potential drug target, WDR35-DT can be targeted with small molecules or antibodies that can inhibit its function. This can be done by modifying the expression or function of the WDR35 gene, or by blocking the activity of the WDR35-DT protein.
WDR35 has also been identified as a potential biomarker for various diseases, including cancer. The expression of WDR35 is often reduced in various diseases, including cancer, which can be used as a biomarker for disease diagnosis and monitoring.
For example, it has been shown that the expression of WDR35 is often reduced in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, it has been shown to be involved in the regulation of cell proliferation and apoptosis, which are important processes that are altered in cancer.
In conclusion, WDR35-DT is a potential drug target and biomarker for various diseases, including cancer. The expression of WDR35 is often reduced in various diseases, and its involvement in the regulation of cell proliferation and apoptosis makes it an attractive target for small molecules or antibodies. Further research is needed to fully understand the role of WDR35-DT as a potential drug target and biomarker for various diseases.
Protein Name: WDR35 Divergent Transcript
The "WDR35-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR35-DT comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B
